Ebba Carbonnier serves as the Director of the Swedish Quantum Life Science Centre, based at Karolinska Institutet. In her role, Carbonnier leads a consortium of academics, healthcare professionals, and industry representatives from organizations such as the Wallenberg Center for Quantum Technology (WACQT), AstraZeneca, IBM, Karolinska Institutet and Swelife, who work together to develop quantum technology applications for healthcare and industry.
Carbonnier also works with the strategy and management of a Swelife-portfolio with national projects in healthcare and life sciences, including gene sequencing, cell- and therapies, and biobanking. Prior to her work at Karolinska Institutet, Carbonnier amassed 14 years of management consulting experience, where she created strategies, managed multidisciplinary teams and implemented large-scale multinational projects for global companies such as AstraZeneca, Microsoft, and Sandvik. Carbonnier holds an MSc and an MBA with a focus on Operations Management.
